✦ LIBER ✦

Tissue Activator of Plasminogen

✍ Scribed by LACK, CHARLES H.; YOUSUF ALI, S.

Book ID: 109632248
Publisher: Nature Publishing Group
Year: 1964
Tongue: English
Weight: 266 KB
Volume: 201
Category: Article
ISSN: 0028-0836
DOI: 10.1038/2011030a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of oral defibrotide on tissue-pla

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance

✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done

Claims on tissue plasminogen activator

✍ Crespi, R. Stephen 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 258 KB

Tissue Plasminogen Activator in Psoriasi

Tissue Plasminogen Activator in Psoriasis.

✍ Jensen, Pamela J.; Baird, Janet; Belin, Dominique; Vassalli, Jean-Dominique; Bus 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

ADMINISTRATION OF EXOGENOUS TISSUE PLASM

ADMINISTRATION OF EXOGENOUS TISSUE PLASMINOGEN ACTIVATOR REDUCES OEDEMA IN MICE LACKING THE TISSUE PLASMINOGEN ACTIVATOR GENE

✍ Kathleen A Stringer; John S Dunn; Daniel L Gustafson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Role of tissue plasminogen activator and

Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction

✍ Waqas Ahmed; Meera Malik; Imran Saeed; Amina Ali Khan; Ahmed Sadeque; Umar Kalee 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB

Tissue plasminogen activator and glial f

Tissue plasminogen activator and glial function

✍ Iordanis Gravanis; Stella E. Tsirka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Tissue plasminogen activator (tPA) is the only FDA‐approved treatment of thrombotic stroke and is a major parenchymal serine protease in the brain. However, it has been implicated in a plethora of brain pathologies, raising concern about its use as a safe therapeutic. tPA is thought to